Income Taxes
For financial reporting purposes, components of income before income taxes are as follows:
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year |
| ($ in millions) | | 2025 | | 2024 | | 2023 |
| United States | | $ | 982 | | | $ | 977 | | | $ | 463 | |
| Foreign | | 150 | | | 160 | | | 93 | |
| Income before income taxes | | $ | 1,132 | | | $ | 1,137 | | | $ | 556 | |
The tax expense for income taxes consists of the following:
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year |
| ($ in millions) | | 2025 | | 2024 | | 2023 |
| Current: | | | | | | |
| Federal | | $ | 167 | | | $ | 194 | | | $ | 63 | |
| State | | 38 | | | 29 | | | 12 | |
| Foreign | | 42 | | | 43 | | | 43 | |
| Total current | | 247 | | | 266 | | | 118 | |
| Deferred: | | | | | | |
| Federal | | 49 | | | (1) | | | (40) | |
| State | | 13 | | | 21 | | | (6) | |
| Foreign | | 7 | | | 7 | | | (18) | |
| Total deferred | | 69 | | | 27 | | | (64) | |
| Total tax expense | | $ | 316 | | | $ | 293 | | | $ | 54 | |
For fiscal 2025, the difference between tax expense and income before taxes at the U.S. federal statutory tax rate, and between the effective tax rate and the U.S. federal statutory tax rate, is as follows:
| | | | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year |
| ($ in millions) | | 2025 | | | | |
| Income before taxes at federal statutory tax rate | | $ | 238 | | | 21.0 | % | | | | | | | | |
| State and local income taxes, net of federal benefit (1) | | 50 | | | 4.4 | | | | | | | | | |
| Tax impact of foreign operations | | 17 | | | 1.5 | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| Effect of cross-border tax laws: | | | | | | | | | | | | |
| U.S. tax on branch income or loss | | (13) | | | (1.1) | | | | | | | | | |
| Other | | (5) | | | (0.4) | | | | | | | | | |
| Tax credits: | | | | | | | | | | | | |
| Research and development credits | | (13) | | | (1.1) | | | | | | | | | |
| Other | | (2) | | | (0.2) | | | | | | | | | |
| Changes in valuation allowance | | 16 | | | 1.4 | | | | | | | | | |
| Nontaxable and nondeductible items: | | | | | | | | | | | | |
| Nondeductible compensation | | 15 | | | 1.3 | | | | | | | | | |
| Other | | (3) | | | (0.3) | | | | | | | | | |
| Changes in unrecognized tax benefits | | 16 | | | 1.4 | | | | | | | | | |
| Total tax expense and effective tax rate | | $ | 316 | | | 27.9 | % | | | | | | | | |
__________
(1)State and local income taxes in New York, California, New Jersey, New York City, Illinois, Florida, and Pennsylvania make up the majority (greater than 50 percent) of the tax effect in this category.
In accordance with the guidance prior to the adoption of ASU No. 2023-09, the difference between the effective tax rate and the U.S. federal statutory tax rate for fiscal 2024 and 2023 is as follows:
| | | | | | | | | | | | | | | | |
| | | | | Fiscal Year |
| | | | | 2024 | | 2023 |
| Federal statutory tax rate | | | | 21.0 | % | | 21.0 | % |
| State and local income taxes, net of federal benefit | | | | 4.4 | | | 2.5 | |
| Tax impact of foreign operations | | | | (2.4) | | | (0.7) | |
| | | | | | |
| Valuation allowances | | | | 3.5 | | | (11.0) | |
| Impact of divestiture activity | | | | — | | | (1.6) | |
| | | | | | |
| | | | | | |
| Other | | | | (0.7) | | | (0.5) | |
| Effective tax rate | | | | 25.8 | % | | 9.7 | % |
During fiscal 2023, we recorded a $65 million benefit for changes in U.S. and foreign valuation allowances and a $32 million benefit related to a U.S. transfer pricing settlement related to our sourcing activities.
Total cash paid for income taxes, net of refunds, by jurisdiction for fiscal 2025 is as follows:
| | | | | | | | | | | | |
| | | Fiscal Year |
| ($ in millions) | | 2025 | | | | |
| Cash paid for income taxes during the period, net of refunds: | | | | | | |
| Federal | | $ | 163 | | | | | |
| State | | 55 | | | | | |
| Foreign | | 17 | | | | | |
| | | | | | |
| | | | | | |
| Total cash paid during the period for income taxes, net of refunds | | $ | 235 | | | | | |
Deferred tax assets (liabilities) consist of the following:
| | | | | | | | | | | | | | |
| ($ in millions) | | January 31, 2026 | | February 1, 2025 |
| Gross deferred tax assets: | | | | |
| | | | |
| Operating lease liabilities | | $ | 1,061 | | | $ | 1,037 | |
| Accrued payroll and related benefits | | 103 | | | 108 | |
| Accruals | | 187 | | | 177 | |
| Inventory capitalization and other adjustments | | 53 | | | 51 | |
| Deferred income | | 43 | | | 43 | |
| | | | |
| | | | |
| Federal, state, and foreign net operating losses | | 188 | | | 179 | |
| | | | |
| Other | | 64 | | | 49 | |
| Total gross deferred tax assets | | 1,699 | | | 1,644 | |
| Valuation allowances | | (311) | | | (261) | |
| Total deferred tax assets, net of valuation allowances | | 1,388 | | | 1,383 | |
| Deferred tax liabilities: | | | | |
| Depreciation and amortization | | (159) | | | (126) | |
| Operating lease assets | | (883) | | | (839) | |
| | | | |
| | | | |
| | | | |
| Other | | (14) | | | (18) | |
| Total deferred tax liabilities | | (1,056) | | | (983) | |
| Net deferred tax assets | | $ | 332 | | | $ | 400 | |
As of January 31, 2026, we had approximately $766 million of state and $603 million of foreign loss carryovers in multiple taxing jurisdictions that could be utilized to reduce tax liabilities of future years. We also had approximately $61 million of foreign tax credit carryovers as of January 31, 2026.
Approximately $628 million of state losses expire between fiscal 2026 and fiscal 2045, and $138 million of the state losses do not expire. Approximately $243 million of the foreign losses expire between fiscal 2026 and fiscal 2045, and $360 million of the foreign losses do not expire. The foreign tax credits begin to expire in fiscal 2029.
Valuation allowances are recorded if, based on the assessment of available evidence, it is more likely than not that some portion, or all, of the deferred tax asset will not be realized. Management must analyze all available positive and negative evidence regarding realization of the deferred tax assets and make an assessment of the likelihood of sufficient future taxable income. We have provided valuation allowances of $311 million on certain federal, state, and foreign deferred tax assets that were not deemed realizable based upon estimates of future taxable income.
On July 4, 2025, the One Big Beautiful Bill Act of 2025 (the “OBBBA”) was enacted in the United States. The Company included the impact of the OBBBA tax legislation in the second quarter of fiscal 2025, the period of enactment, and the impact was not material to the Consolidated Financial Statements.
The activity related to our unrecognized tax benefits is as follows:
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year |
| ($ in millions) | | 2025 | | 2024 | | 2023 |
| Balance at beginning of fiscal year | | $ | 374 | | | $ | 343 | | | $ | 344 | |
| Increases related to current year tax positions | | 15 | | | 13 | | | 12 | |
| Prior year tax positions: | | | | | | |
| Increases | | 4 | | | 22 | | | 21 | |
| Decreases | | (1) | | | (1) | | | (30) | |
| Lapse of Statute of Limitations | | (1) | | | (1) | | | (1) | |
| Cash settlements | | — | | | (1) | | | (3) | |
| Foreign currency translation | | 3 | | | (1) | | | — | |
| Balance at end of fiscal year | | $ | 394 | | | $ | 374 | | | $ | 343 | |
Of the total unrecognized tax benefits as of January 31, 2026, February 1, 2025, and February 3, 2024, approximately $373 million, $354 million, and $325 million, respectively, represents the amount that, if recognized, would favorably affect the effective income tax rate in future periods.
During fiscal 2025, 2024, and 2023, net interest expense of $22 million, $17 million, and $4 million, respectively, has been recognized on the Consolidated Statements of Operations relating to income tax liabilities.
As of January 31, 2026 and February 1, 2025, the Company had total accrued interest related to income tax liabilities of $88 million and $66 million, respectively. There were no accrued penalties related to income tax liabilities as of January 31, 2026 or February 1, 2025.
The Company conducts business globally, and as a result, files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business, we are subject to examination by taxing authorities throughout the world, including such major jurisdictions as the United States, Canada, France, the United Kingdom, China, Hong Kong, Japan, and India. We are no longer subject to U.S. federal income tax examinations for fiscal years before 2009, and with few exceptions, we also are no longer subject to U.S. state, local, or non-U.S. income tax examinations for fiscal years before 2010.
The IRS has examined the Company’s federal income tax returns and has sought to disallow research credits for tax years 2009 through 2013. Having exhausted all administrative avenues, the Company filed a petition in U.S. Tax Court on December 20, 2024. The Company believes the research credits taken are appropriate and intends to defend its position. The gross amount of research credits at issue for tax years 2009 through 2013 is approximately $41 million.